Vladimir A. Varshavsky

Vladimir A. Varshavsky

Auto-generated profile, based on publicly available information

Vladimir A. Varshavsky

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2017 in Current Urology Reports
Verified
Journal Article
Open access
PDF file
MGMarina O. Golovastova
Marina O. Golovastova
DKDmitry O. Korolev
Dmitry O. Korolev
LTLarisa V. Tsoy
Larisa V. Tsoy
VVVladimir A. Varshavsky
Vladimir A. Varshavsky
WXWan-Hai Xu
Wan-Hai Xu
Andrey A. Zamyatnin Jr.Andrey A. Zamyatnin Jr.
Andrey A. Zamyatnin Jr.
Renal cell carcinoma (RCC) ranks the first death rate among the urogenital tumors, whereas its incidence follows the incidences of prostate and bladder cancer. The diagnosis of RCC at early stages allows immediately undertaking appropriate treatment, which significantly increases patients’ survival rate. Early and accurate diagnosis avoids inadequate treatment, provides the disease progression forecast, and permits to apply more efficient therapy. Unfortunately, the small renal tumors are usually asymptomatic resulting in the late diagnosis and, therefore, low efficacy of treatment. Thus, sensible and preventive biomarkers are essential for early RCC detection and monitoring of its progression. So far, many attempts were performed aimed at recognizing novel informative kidney tumor biomarkers applicable for early detection of the disease and possessing prognostic and predictive capabilities. This review summarizes recent advances in renal tumor biomarkers recognition, their diagnostic and prognostic values, and clinical feasibility.

26 January 2016 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
MGMarina O. Golovastova
Marina O. Golovastova
LTLarisa V. Tsoy
Larisa V. Tsoy
ABAnna V. Bocharnikova
Anna V. Bocharnikova
DKDmitry O. Korolev
Dmitry O. Korolev
OGOlga S. Gancharova
Olga S. Gancharova
PPPavel P. Philippov
Pavel P. Philippov

Verified
Journal Article
Open access
PDF file
NCNatalia V. Chebotareva
Natalia V. Chebotareva
AVAnatoliy Vinogradov
Anatoliy Vinogradov
LTLarisa Tsoy
Larisa Tsoy
VVVladimir Varshavskiy
Vladimir Varshavskiy
ESEkaterina Stolyarevich
Ekaterina Stolyarevich
Alexey S. KononikhinAlexey S. Kononikhin
Alexey S. Kononikhin
It is suggested that activated CD44+ cells play a profibrogenic role in the pathogenesis of active glomerulopathies. Complement activation is also involved in renal fibrogenesis. The aim of the study was to evaluate the role of the activation of CD44+ cells in the kidney tissue and complement components’ filtration to the urine as factors of renal tissue fibrosis in patients with glomerulopathies. In total, 60 patients with active glomerulopathies were included in our study: 29 patients with focal segmental glomerulosclerosis (FSGS), 10 patients with minimal change disease (MCD), 10 patients with membranous nephropathy (MN), and 11 patients with IgA nephropathy. The immunohistochemical peroxidase method was used to study the expression of CD44+ in kidney biopsies. Components of complement were analyzed in urine by the multiple reaction monitoring (MRM) approach using liquid chromatography. Strong CD44 expression was noted predominantly in PEC and mesangial cells (MC) in patients with FSGS, and to a lesser extent, in patients with MN and IgA nephropathy, and it was absent in patients with MCD. Expression of profibrogenic CD44+ in glomeruli correlated with the levels of proteinuria and complement C2, C3, and C9 components, and CFB and CFI in urine. The CD44+ expression scores in the renal interstitium correlated with the level of C3 and C9 components of complement in the urine and the area of tubulo-interstitial fibrosis. The strongest expression of CD44+ was found in the glomeruli (MC, PEC, and podocytes) of patients with FSGS compared with other glomerulopathies. The CD44 expression score in the glomeruli and interstitium is associated with high levels of complement components in the urine and renal fibrosis.

22 May 2014 in The Prostate
Verified
Journal Article
Closed access
PDF file
PGP.V. Glybochko
P.V. Glybochko
EZE.G. Zezerov
E.G. Zezerov
AGA.I. Glukhov
A.I. Glukhov
YAYu.G. Alyaev
Yu.G. Alyaev
SSS.E. Severin
S.E. Severin
AVAndrey Z. Vinarov
Andrey Z. Vinarov

1 February 2019 in Biochimie
Verified
Journal Article
Closed access
ABAlexey Baldin
Alexey Baldin
AGAlena N. Grishina
Alena N. Grishina
DKDmitry O. Korolev
Dmitry O. Korolev
EKEkaterina B. Kuznetsova
Ekaterina B. Kuznetsova
MGMarina O. Golovastova
Marina O. Golovastova
Andrey A. Zamyatnin Jr.Andrey A. Zamyatnin Jr.
Andrey A. Zamyatnin Jr.

3 August 2022 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Open access
PDF file
NTNataliа P. Teplyuk
Nataliа P. Teplyuk
OGOlga V. Grabovskaya
Olga V. Grabovskaya
DKDiana T. Kusraeva
Diana T. Kusraeva
VVVladimir A. Varshavsky
Vladimir A. Varshavsky
ТПТеплюк Наталия Павловна
Теплюк Наталия Павловна
BACKGROUND: Pyoderma gangrenosum is a rare inflammatory skin disease that currently belongs to the group of neutrophilic dermatoses. AIMS: Development of epidemiological, clinical, laboratory characteristics of patients with pyoderma gangrenosum, as well as the treatment of this disease. MATERIALS AND METHODS: The study revealed 30 patients, 16 (53%) were women, the average age at the time of diagnosis was 5916.3 years. The most common localization of rashes was the lower leg 20 patients (67%), lesions of the skin of the face, genitals, and breast rarely noted, in one case, respectively. In 14 patients (47%), two or more ulcers were detected at the same time (max. 9 ulcers). The pathergy phenomenon was positive in 23 patients (77%) of 30. Ulcerative pyoderma gangrenosum occurred in 25 (83%), and extracutaneous pyoderma gangrenosum with lung involvement was identified in one patient. The most common associated disease was rheumatoid arthritis in 6 patients (20%), there were also rare associated diseases, such as hepatitis C two cases, multiple endocrine neoplasia syndrome type 1, autoimmune hepatitis, non-Hodgkins lymphoma by one observation. Histological examination revealed neutrophilic infiltration of the dermis in 30 patients (100%), and the presence of leukocytoclastic vasculitis in 16 (53%). Complete scarring during the treatment was observed in 22 patients (73%). Relapses during the observation period were observed in 12 patients (40%), the number of deaths was two cases. CONCLUSIONS: One of the largest case series of pyoderma gangrenosum to date is presented. During the examination of patients, it was found that neutrophilic infiltration of the dermis is a characteristic sign of the disease. Rare comorbidities (multiple endocrine neoplasia syndrome type 1, autoimmune hepatitis, hepatitis C, non-Hodgkins lymphoma) have been found. A sufficiently large percentage of relapses indicates the need for further research to develop an additional examination method for the purpose of modern diagnostics and justification for the timely prescription of targeted therapy.